https://orcid.org/0000-0002-5116-7690
References
- Bellieni C. The Best Age for Pregnancy and Undue Pressures. J Family Reprod Health. 2016;10(3):104–107.
- Statistical Office of the European Communities. EUROSTAT fertility statistics [cited 2020 Jan 20]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php/Fertility_statistics.
- Nakić Radoš S, Košec V, Gall V. The psychological effects of prenatal diagnostic procedures: maternal anxiety before and after invasive and noninvasive procedures. Prenat Diagn. 2013;33(12):1194–1200.
- Online Mendelian Inheritance in Man, OMIM (TM). Down syndrome. Baltimore: Johns Hopkins University. Number:#190685: Updated 15 February 2017 [cited 2020 Jan 27]. Available from: http://omim.org/entry/190685
- Carlson LM, Vora NL. Prenatal diagnosis: screening and diagnostic tools. Obstet Gynecol Clin North Am. 2017;44(2):245–256.
- ACOG Committee on Practice Bulletins. ACOG practice bulletin no. 88: invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110(6):1459–1467.
- Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2015;45:249–266.
- van den Berg M, Timmermans DR, Kleinveld JH, et al. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women's reasons. Prenat Diagn. 2005;25(1):84–90.
- Akolekar R, Beta J, Picciarelli G, et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:16–26.
- Spencer K. Screening for Down syndrome. Scand J Clin Lab Invest. 2014;74(Suppl 244):41–47.
- ACOG Committee on Practice Bulletins. ACOG practice bulletin no.163: screening for fetal aneuploidy. Obstet Gynecol. 2016;127(5):108–122.
- Kosec V, Zec I, Tislaric-Medenjak D, et al. Pregnant women’s knowledge and attitudes to prenatal screening for fetal chromosomal abnormalities: Croatian multicentric survey. Coll Antropol. 2013;37(2):483–489.
- Rostant K, Steed L, O'Leary P. Survey of the knowledge, attitudes and experiences of Western Australian women in relation to prenatal screening and diagnostic procedures. Aust NZ J Obstet Gynaecol. 2003;43:134–138.
- Gitsels-van der Wal JT, Verhoeven PS, Manniën J, et al. Factors affecting the uptake of prenatal screening tests for congenital anomalies: a multicenter prospective cohort study. BMC Pregnancy Childbirth. 2014;14:264.
- Garcia E, Timmermans DRM, van Leeuwen E. Reconsidering prenatal screening: an empirical–ethical approach to understand moral dilemmas as a question of personal preferences. J Med Ethics. 2009;35(7):410–414.
- Reid B, Sinclair M, Barr O, et al. Women’s preferences for antenatal screening for Down syndrome in Northern Ireland: a choice experiment. Evidence Based Midwifery. 2014;12(4):112–120.
- Crombag NM, Vellinga YE, Kluijfhout SA, et al. Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res. 2014;14(1):437.
- Crombag NM, Boeije H, Iedema-Kuiper R, et al. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study. BMC Pregnancy Childbirth. 2016;16:121.
- Crombag NM1, Bensing JM, Iedema-Kuiper R, et al. Determinants affecting pregnant women's utilization of prenatal screening for Down syndrome: a review of the literature. J Matern Fetal Neonatal Med. 2013;26(17):1676–1681.